The canine atopic dermatitis market size will grow at USD 319.37 million from 2021 to 2026, owing to the increasing adoption of pets.

new york, April 12, 2023 /PRNewswire/ – The Canine atopic dermatitis market The amount is expected to increase 319.37 million dollars From 2021 to 2026, in A CAGR 7.75%; According to a recent market survey conducted by Technavio. The growth of the market is driven by increasing pet adoption, increasing awareness about disease prevention and pet insurance, and growing importance of treating allergic conditions in animals. Technavio provides an up-to-date analysis of the current global market situation and overall market situation. See a sample report.

Technavio provides global canine atopic dermatitis market vendor analysis:

Established vendors have strong financial capabilities and technical capabilities to deliver high-quality products. Small suppliers compete with established suppliers by using low pricing strategies and by consolidating their customer base in local or regional markets. Technavio Bioceltics comprehensively analyzed 15 major suppliers, including Spolka Axiina, Ceva Sante Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Novartis AG, Toray Industries Inc., Vetoquinol UK Ltd., Vimian Group AB, Virbac and Zoetis Inc.

Supplier’s Provisions –

• Bioceltics spolka axijana – Under the Bioceltics brand, the company offers solutions for canine atopic dermatitis that are treated by eliminating the allergens that cause the sensitivity.
• Dechra Pharmaceuticals Pvt. Under the Dechra brand, the company offers canine atopic dermatitis solutions that help dogs that scratch or lick constantly or suffer from atopic dermatitis.
• Elanco Animal Health Inc. – Under the Atopica brand name, the company offers solutions for canine atopic dermatitis that reduce skin lesions while providing proven long-term relief.

Charts and data tables about market and segment sizes for the forecast period (2022-2026) are covered in this report. Download the sample report

Key benefits for industry players and stakeholders –

• The report provides information on the importance of supplier inputs, including: R&D, CAPEX and Technology.
• It also provides detailed analysis Market Competitive Landscape and Vendor Product Offerings.
• The report provides qualitative and quantitative analysis of vendors to help clients understand the broader business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed and quantitatively analyzed to categorize vendors as pure play, category focused, industry focused and diversified, vendors as dominant, leading, strong, transient and weak.

Expand jobs for the future – to get important details, Request a custom report.

Get overview of Endoscopic Closure Devices market by industry experts to evaluate and develop growth strategies. Download the sample

Market segmentation:

This Canine Atopic Dermatitis market research broadly covers the market by product (antihistamines, glucocorticoids, progestational compounds, and others) and geography.North America, Europe, Asiaand ROW).

• Market share growth by Antihistamines class It will be beneficial for market growth during the review period. The term “antihistamines” refers to drugs that are frequently used to treat allergies. In addition, they help control dog skin allergies. As a result, the growth of this market segment is due to antihistamine drugs, which are mostly prescribed for the treatment of allergies and are more cost-effective and easily available.

Market volatility:

Key Drivers:

• Increasing humanization of pets is one of the major factors supporting the growth of the canine atopic dermatitis market.
• To prolong the lives and improve the health of their pets, pet owners are looking for high quality medical supplies and veterinary care. This is evident in both developing and emerging markets.
• Pet owners around the world are working to ensure that the ingredients and manufacturing standards of all pet care products are of the same high standard as for humans.
• Younger pet owners are putting more effort into caring for their animals.
• During the forecast period, the demand for drugs for the treatment of canine atopic dermatitis will be driven by the ever-increasing demand and demand for pet health products.

Major trends

• Increasing M&A is a new trend supporting the growth of the Canine Atopic Dermatitis market.
• The separation of Elanco Animal Health Inc. from Eli Lilly & Co. was completed in 2010 March 2019. in March 2021, Virbac found some Elanco projects related to the creation of new parasites. Itrafungol and Clomicalm, two of the companion animal products, are licensed worldwide by Virbac.
• The proposal to acquire the animal health division of Bayer AG by Elco Animal Health Inc. has been approved by the European Union Commission in 2020. The second largest animal health company in the world was formed as a result of this acquisition.
• The market for drugs to treat canine contact atopic dermatitis will expand due to mergers and acquisitions during the forecast period.

Key Challenges:

• Stringent global regulatory requirements are a challenge hindering the growth of the canine atopic dermatitis market.
• To avoid the effects, manufacturers must comply with the strict control criteria implemented.
• Before being imported from one country to another, new drugs for use in animals must first have an approved application.
• Approved New Animal Drug Applications (NADA), Abbreviated New Animal Drug Applications (ANADA), Investigational New Animal Drug Applications (INAD), General Investigational New Animal Drug Applications (JINDA), Conditional Approval (CNADA), and Index List are all examples. Drug applications.
• During the forecast period, the demand for drugs to treat canine atopic dermatitis is likely to be hampered by the presence of such stringent regulations.

For detailed insights into inclusion and exclusion, Buy the report

Sign up for a free trial today and get instant access to 17,000+ market research reports.
Technevio SUBSCRIPTION platform

What are the key information covered in this Canine Atopic Dermatitis Market Report?

• CAGR of the market during the forecast period
• In the year Detailed information on the factors driving the growth of the canine atopic dermatitis market between 2022 and 2026
• An accurate estimate of the size of the Canine Atopic Dermatitis market and its contribution to the market with a focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the Canine Atopic Dermatitis Market North America, Europe, Asiaand ROW
• In-depth analysis of the competitive landscape of the market and detailed information about the vendors
• Comprehensive analysis of factors challenging the growth of Canine Atopic Dermatitis market vendors

Related Articles:

of Animal welfare market The volume is expected to increase by USD 190.96 million from 2021 to 2026, and the market growth will increase at a CAGR of 5.85%. The report broadly covers the Animal Sedatives market segmentation by Type (Parental and Oral) and Geography (Geography).North America, Europe, Asia, and Rest of the World (ROW)). The increasing prevalence of animal diseases is particularly driving the growth of the animal sedation market.

of Animal genetics market It is estimated to grow at a CAGR of 5.48% between 2022 and 2027. The market size is said to increase by USD 1,534.79 million. This report broadly covers market segmentation by solution (live animals, genetic testing services, and genetic materials), end user (research centers, hospitals and clinics, and diagnostic centers), and geography.North America, Europe, Asia, and Rest of the World (ROW)). Growing demand for genetic testing services to reduce animal diseases is driving the growth of the market.

Look for Technavio’s HEarth careMarket reports

details of the situation

executive summary

Market landscape

• Market ecology
• Value chain analysis

Market size

• Market definition
• Market segment analysis
• Market Size 2021
• Market Outlook: Forecast for 2021 – 2026

Five forces analysis

• Bargaining power of buyers
• Bargaining power of suppliers
• The threat of new arrivals
• Intimidation of substitutes
• The threat of competition
• Market situation

Market segmentation by product

• Market segments
• Compare by product
• Antihistamines – Market Size and Forecast 2021-2026
• Glucocorticoids – Market Size and Forecast 2021-2026
• Progestational Compounds – Market Size and Forecast 2021-2026
• Others – Market Size and Forecast 2021-2026
• Market opportunity by product

Customer landscape

Geographical landscape

• Geographical distribution
• Geographical comparison
• North America – Market size and forecast 2021-2026
• Europe – Market size and forecast 2021-2026
• Asia – Market size and forecast 2021-2026
• ROW – Market Size and Forecast 2021-2026
• Major countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

The landscape of the supplier

• Overview
• Disruption of landscape

Supplier analysis

• Sellers are covered
• Market positioning of suppliers
• Bioceltix Spolka Akcyjna
• Ceva Sante Animale
• Dechra Pharmaceuticals Pvt
• Elanco Animal Health Inc.
• Novartis AG
• Toray Industries Inc.
• Vetoquinol UK Ltd.
• Vimian Group AB
• Virback
• Zoetis Inc.

Appendix

• Scope of the report
• Exchange rates for US$
• Research methods
• List of abbreviations

about us
Technavio is a leading global technology research and consulting company. Their research and analysis focuses on market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market position. With more than 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and inventories, covering 800 technologies in 50 countries. Their client base consists of all types of enterprises, including over 100 Fortune 500 companies. This growing customer base is supported by Technovio’s comprehensive coverage, extensive research and practical market insights to identify opportunities in existing and potential markets and assess their competitiveness in changing market conditions.

Connect
Technavio Research
Jesse Madda
Media and Marketing Executive
USA: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
website: www.technavio.com/

Source Technavio